Bora Pharmaceuticals Co., Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 6472.TW | 1795.TW | AARTIDRUGS.BO | TEVA | APN.JO | TAK | |
|---|---|---|---|---|---|---|
| Market cap | 52.75B | 46.89B | 35.59B | 47.37B | 68.44B | 63.67B |
| P/E (TTM) | 29.0 | 12.3 | 18.6 | 67.7 | — | — |
| Forward P/E | 13.0 | 7.4 | 14.0 | 13.2 | 11.7 | 37.6 |
| Price/book | 3.5 | 2.0 | 2.3 | 6.1 | 0.9 | 1.3 |
| Dividend yield | 2.42% | 1.47% | 0.50% | — | 1.50% | 3.07% |
| 1-year change | −36.07% | −39.08% | −21.36% | +115.34% | +56.49% | +42.01% |
| Today | +0.12% | +0.57% | −2.29% | −0.56% | −0.41% | −0.75% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All 6472.TW news ›Taiwan's Bora Pharmaceuticals Posts Record September Revenue of NT$2.33 Billion, Up 35% Year-over-Year
Bora Pharmaceuticals reported September consolidated revenue of NT$2.33 billion (approximately $72.9 million), up 6.44% month-over-month and 35.13% year-over-year, setting a new single-month record for the second time since June.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
finance.biggo.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.